2022 Year End Review
2022 Year End Review
Forward Looking Statement
In this presentation, we have included statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as "estimate," "project," "plan," "believe," "anticipate," "intend," "planned," "potential" and similar expressions, or future or conditional verbs such as "will," "should," "would," "could," and "may," or the negative of those expressions or verbs, identify forward-looking statements. We caution readers that these statements are not guarantees of future performance. Forward-looking statements are not historical facts but instead represent only our beliefs regarding future events, which may by their nature be inherently uncertain and some of which may be outside our control. These statements may relate to plans and objectives with respect to the future, among other things which may change. We are alerting you to the possibility that our actual results may differ, possibly materially, from the expected objectives or anticipated results that may be suggested, expressed or implied by these forward-looking statements. Important factors that could cause our results to differ, possibly materially, from those indicated in the forward-looking statements include, among others, those discussed under "Risk Factors" .
Any or all of management's forward-looking statements here or in other publications may tuout to be incorrect and are based on management's current belief or opinions.
- adverse impacts from changes in prevailing interest rates; (25) events or circumstances that result in the impairment of our intangible assets and/or goodwill that was recorded in connection with
Ambac's acquisitions; (26) risks associated with the expected discontinuance of theLondon Inter-Bank Offered Rate; (27) factors that may negatively influence the amount of installment premiums paid toAmbac ; (28) the risk of litigation and regulatory inquiries or investigations, and the risk of adverse outcomes in connection therewith; (29) the Company's ability to adapt to the rapid pace of regulatory change; (30) actions of stakeholders whose interests are not aligned with broader interests ofAmbac's stockholders; (31) system security risks, data protection breaches and cyber attacks; (32) regulatory oversight ofAmbac Assurance UK Limited ("AmbacUK ") and applicable regulatory restrictions may adversely affect our ability to realize value from AmbacUK or the amount of value we ultimately realize;
- failures in services or products provided by third parties; (34) political developments that disrupt the economies where the Company has insured exposures; (35) our inability to attract and retain qualified executives, senior managers and other employees, or the loss of such personnel; (36) fluctuations in foreign currency exchange rates; (37) failure to realize our business expansion plans or failure of such plans to create value; (38) greater competition for our specialty property and casualty insurance business and/or our insurance distribution business; (39) loss or lowering of the AM Best rating for our property and casualty insurance company subsidiaries; (40) disintermediation within the insurance industry or greater competition from technology-based insurance solutions; (41) changes in law or in the functioning of the healthcare market that impair the business model of our accident and health managing general underwriter; and (42) other risks and uncertainties that have not been identified at this time.
2
2022 Key Accomplishments
Transformational achievements across the entire platform
AFG
$522 million of Net Income$740 million EBITDA1- +24% Book Value per Share
- +50% Adjusted Book Value per Share2
Specialty P&C
- +116% of Premium Production
- 2x
Program Partners to 14 - 2 MGA/brokerAcquisitions
- 1 De Novo Incubation Announced3
Legacy
~$2 billion of RMBS Settlements($1.8) billion of Debt Reduction$150 million Discount Capture- Puerto Rico Restructured- PRIFA, CCDA, and HTA
1. For EBITDA reconciliation to pre-tac net income see
3 2. See slide 14 for Adjusted Book Value reconciliation to Book Value
- Second de novo incubation announced in
January 2023 - 2-taxGAAP Net Income
2022 Key Accomplishments
Ambac De-Leveraged and De-Risked in 2022
De-Leverage Ratios to ABV
- (100%) R&W Recoverable Reduction1
- (74%) Debt Leverage Reduction
De-Risking Activities
- (77%) Puerto Rico Exposure Reduction
- (51%) Net Reserve Reduction (ex. R&W)
- (26%) Adverse Credit Reduction
- (19%) Net Par Outstanding Reduction
4 |
1. |
When combined with the Nomura related debt reduction in 1Q23 |
2. |
2-tax GAAP Net Income |
Ambac Assurance What's Next?
Acceleration of strategic options following settlements totaling
Settlement amount:
Settlement Overview
Future Strategic Considerations
Re-imagining AAC as a run-off portfolio as we strive towards being in a positive carry position following
|
|
Senior debt |
Net gain on settlement |
repaid |
Nomura Settlement
$146 million1 |
|
Senior debt |
Net gain on settlement |
repaid |
Regulatory capital reassessment
Strategic reinsurance transactions
Partial or full sale
Asset & Liability Management
Unlocking future value from NOLs
1. Senior debt redeemed in full
5
Attachments
Disclaimer
Fourth Quarter 2022 Highlights
Consumer group appeals court loss in dispute over state insurance records [The San Diego Union-Tribune]
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News